Incidence and prognostic implications of late bleeding events after percutaneous mitral valve repair

about

Incidence and prognostic implications of late bleeding events after percutaneous mitral valve repair

Item

http://www.wikidata.org/entity/Q58718637

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2018

@uk

name

Incidence and prognostic impli ...... rcutaneous mitral valve repair

@en

Incidence and prognostic impli ...... rcutaneous mitral valve repair

@nl

type

Item

label

Incidence and prognostic impli ...... rcutaneous mitral valve repair

@en

Incidence and prognostic impli ...... rcutaneous mitral valve repair

@nl

prefLabel

Incidence and prognostic impli ...... rcutaneous mitral valve repair

@en

Incidence and prognostic impli ...... rcutaneous mitral valve repair

@nl

P1476

Incidence and prognostic impli ...... rcutaneous mitral valve repair

@en

P2093

Armando Pérez de Prado

http://www.w3.org/2001/XMLSchema#string

Carlos Cuellas Ramón

http://www.w3.org/2001/XMLSchema#string

Carlos Minguito-Carazo

http://www.w3.org/2001/XMLSchema#string

Carmen Garrote-Coloma

http://www.w3.org/2001/XMLSchema#string

David Alonso-Rodríguez

http://www.w3.org/2001/XMLSchema#string

Felipe Fernández-Vázquez

http://www.w3.org/2001/XMLSchema#string

Ignacio Iglesias-Gárriz

http://www.w3.org/2001/XMLSchema#string

Javier Gualis Cardona

http://www.w3.org/2001/XMLSchema#string

Julia Vidán Estévez

http://www.w3.org/2001/XMLSchema#string

María López Benito

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium

Combined antiplatelet and anticoagulant therapy: clinical benefits and risks

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.

Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry.

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry

Anemia and mortality in heart failure patients a systematic review and meta-analysis.

Combining antiplatelet and anticoagulant therapies.

P304

16-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJCHA.2018.09.004

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tomás Benito-González

Rodrigo Estévez-Loureiro

P577

2018-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30255126

http://www.w3.org/2001/XMLSchema#string

P932

6148729

http://www.w3.org/2001/XMLSchema#string